Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -261,436 | -162,696 | -76,896 | -295,350 | -209,445 |
| Depreciation Amortization | 2,046 | 1,237 | 557 | 1,264 | 829 |
| Accounts payable and accrued liabilities | -7,289 | -6,297 | -11,703 | 2,451 | -2,818 |
| Other Working Capital | -19,790 | -20,141 | -18,978 | 37,604 | 18,731 |
| Other Operating Activity | 42,172 | 28,520 | 22,953 | 29,174 | 26,361 |
| Operating Cash Flow | $-244,297 | $-159,377 | $-84,067 | $-224,857 | $-166,342 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -139,954 | -190,492 | -186,829 | 206,903 | 140,487 |
| PPE Investments | -443 | -104 | -35 | -217 | -188 |
| Investing Cash Flow | $-140,397 | $-190,596 | $-186,864 | $206,686 | $140,299 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 65,000 | 50,000 | 35,000 | 50,000 | 50,000 |
| Common Stock Issued | 50,563 | 45,908 | 17,903 | 264,337 | 0 |
| Other Financing Activity | -363 | -288 | -213 | -886 | -886 |
| Financing Cash Flow | $115,200 | $95,620 | $52,690 | $313,451 | $49,114 |
| Beginning Cash Position | 331,549 | 331,549 | 331,549 | 36,269 | 36,269 |
| End Cash Position | 62,055 | 77,196 | 113,308 | 331,549 | 59,340 |
| Net Cash Flow | $-269,494 | $-254,353 | $-218,241 | $295,280 | $23,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | -244,297 | -159,377 | -84,067 | -224,857 | -166,342 |
| Capital Expenditure | -443 | -104 | -35 | -217 | -188 |
| Free Cash Flow | -244,740 | -159,481 | -84,102 | -225,074 | -166,530 |